FIELD: biotechnology.
SUBSTANCE: invention relates to creation of a strain of recombinant cell line CHO-K1-H5 producing recombinant hemagglutinin of influenza A (H5N8) virus, which induces a specific immune response against highly pathogenic influenza A (H5N8) virus. RHA/H5 gene has been designed, plasmid DNA pVL3-HA/H5 having the nucleotide sequence SEQ ID NO: 1 5989 bp, molecular weight 3,700,705 Da, containing the target gene coding protein-immunogen HA/H5 SEQ ID NO: 2. Strain of the recombinant cell line CHO-K1-H5 and recombinant hemagglutinin of the influenza A (H5N8) virus, produced by the above cell line strain CHO-K1-H5 and inducing a specific immune response against the highly pathogenic influenza A (H5N8) virus.
EFFECT: recombinant cell line CHO-K1-H5 producing recombinant protein hemagglutinin of influenza A (H5N8) virus, which is capable of inducing a specific protective humoral immune response against influenza A (H5N8) virus.
3 cl, 8 dwg
Authors
Dates
2024-09-23—Published
2024-03-19—Filed